Tower Research Capital LLC (TRC) - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 50 filers reported holding MERSANA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$61,352
+151.9%
48,309
+552.6%
0.00%
+100.0%
Q2 2023$24,355
+25269.8%
7,403
-68.4%
0.00%
-66.7%
Q1 2023$96
-55.3%
23,450
-36.1%
0.00%
-66.7%
Q4 2022$215
-99.9%
36,698
+0.8%
0.01%
+125.0%
Q3 2022$246,000
+530.8%
36,410
+328.8%
0.00%
+300.0%
Q2 2022$39,000
+14.7%
8,492
+0.8%
0.00%
Q1 2022$34,000
-72.6%
8,425
-57.5%
0.00%
-100.0%
Q4 2021$124,000
+51.2%
19,846
+128.3%
0.00%0.0%
Q3 2021$82,000
+3.8%
8,693
+49.2%
0.00%0.0%
Q2 2021$79,000
-42.3%
5,825
-31.5%
0.00%0.0%
Q1 2021$137,000
+661.1%
8,501
+1153.8%
0.00%
+100.0%
Q4 2020$18,000
-85.7%
678
-90.0%
0.00%0.0%
Q3 2020$126,000
-43.5%
6,791
-28.6%
0.00%
-88.9%
Q2 2020$223,000
+5475.0%
9,512
+1128.9%
0.01%
Q4 2019$4,000
-66.7%
774
-89.8%
0.00%
-100.0%
Q3 2019$12,000
-14.3%
7,568
+125.9%
0.00%0.0%
Q2 2019$14,000
+75.0%
3,350
+116.1%
0.00%
Q1 2019$8,000
-82.2%
1,550
-85.8%
0.00%
-100.0%
Q4 2018$45,000
+18.4%
10,929
+189.1%
0.00%0.0%
Q3 2018$38,000
-2.6%
3,781
+72.6%
0.00%
+50.0%
Q2 2018$39,000
+680.0%
2,190
+622.8%
0.00%
Q3 2017$5,0003030.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders